Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.  
Home Contact us sitemap
www.ty-pharm.com
  Home  
  News releases
Tianyuan's Flu Vaccine exported to South-America
Publisheradmin Date:2007-1-15 Font: Big Medium Small

In January 2007, Tianyuan's Flu Vaccine "YUGANNING" was for the first time exported to South-America after previous exports to Asian and European markets. Registrations in other countries are in progress, as Tianyuan wants to increase its' export business and to explore new opportunities.

About Influenza
Influenza is an infection of the respiratory tract caused by influenza virus. It involves a combination of respiratory (cough, sore throat) and constitutional (fever, headache, muscle aches) symptoms. In Children, older adults and people with a range of pre-existing medical conditions influenza infections can lead to serious and even life threatening complications.
As the circulating viruses change by mutation infections can occur repeatedly throughout life and protection by vaccination requires annual dosing with updated vaccines. Seasonal vaccination prevents influenza and reduces the impact of epidemics.
Tianyuan's influenza vaccine YUGANNING is an inactivated split vaccine, produced on embryonated chicken eggs. The vaccine is manufactured according to the seasonal WHO recommendation for Northern and Southern Hemisphere. The vaccine's quality level is comparable to internationally available vaccines. Tianyuan aspires to get the WHO pre-qualification status for YUGANNING.


Print || Close Windows
Copyright(C)2008,Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. All Rights Reserved.
 Supported by  ChinaPharmNet Toocle